C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysisPeter Taylor, Jan Dutz, Kimberly S. Collins et al.|The Lancet Diabetes & Endocrinology|2023Cited by 58
MEDI-563, a Humanized Anti-IL-5Ra Antibody with Enhanced Effector Function, Induces Reversible Blood Eosinopenia in Mild AsthmaticsJennifer L. Reed, Barbara White, Alison A. Humbles et al.|Journal of Allergy and Clinical Immunology|2008Cited by 10